Susquehanna International Group’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $169K | Buy |
145,769
+40,082
| +38% | +$46.5K | ﹤0.01% | 5647 |
|
|
2025
Q1 | $168K | Buy |
105,687
+61,707
| +140% | +$98.1K | ﹤0.01% | 5611 |
|
|
2024
Q4 | $133K | Sell |
43,980
-77,115
| -64% | -$234K | ﹤0.01% | 5541 |
|
|
2024
Q3 | $446K | Buy |
121,095
+77,018
| +175% | +$283K | ﹤0.01% | 3818 |
|
|
2024
Q2 | $180K | Buy |
44,077
+17,050
| +63% | +$69.7K | ﹤0.01% | 4817 |
|
|
2024
Q1 | $426K | Sell |
27,027
-8,565
| -24% | -$135K | ﹤0.01% | 3748 |
|
|
2023
Q4 | $539K | Buy |
35,592
+11,254
| +46% | +$170K | ﹤0.01% | 3747 |
|
|
2023
Q3 | $488K | Buy |
24,338
+9,584
| +65% | +$192K | ﹤0.01% | 3437 |
|
|
2023
Q2 | $416K | Sell |
14,754
-64,533
| -81% | -$1.82M | ﹤0.01% | 3860 |
|
|
2023
Q1 | $1.36M | Buy |
79,287
+57,080
| +257% | +$982K | ﹤0.01% | 2451 |
|
|
2022
Q4 | $447K | Sell |
22,207
-52,814
| -70% | -$1.06M | ﹤0.01% | 3381 |
|
|
2022
Q3 | $1.63M | Buy |
75,021
+66,153
| +746% | +$1.43M | ﹤0.01% | 1897 |
|
|
2022
Q2 | $249K | Sell |
8,868
-21,298
| -71% | -$598K | ﹤0.01% | 4254 |
|
|
2022
Q1 | $1.39M | Sell |
30,166
-1,727
| -5% | -$79.7K | ﹤0.01% | 2436 |
|
|
2021
Q4 | $2.68M | Sell |
31,893
-16,458
| -34% | -$1.38M | ﹤0.01% | 1677 |
|
|
2021
Q3 | $3.22M | Buy |
48,351
+30,978
| +178% | +$2.06M | ﹤0.01% | 1521 |
|
|
2021
Q2 | $924K | Buy |
17,373
+10,863
| +167% | +$578K | ﹤0.01% | 3078 |
|
|
2021
Q1 | $282K | Buy |
6,510
+118
| +2% | +$5.11K | ﹤0.01% | 4425 |
|
|
2020
Q4 | $332K | Buy |
+6,392
| New | +$332K | ﹤0.01% | 3807 |
|